BN Business News
Add your company to Business Communicator →

BUSINESS NEWS

Search Business News

Find articles by title or summary.

7/30/2026

Oilseed crushing statistics, June 2026

Oilseed processors crushed 1.2 million tonnes of canola in June 2026, a 12.8% increase from May 2026 and a 36.6% increase from June 2025. Oil production reached 494.6 thousand tonnes in June 2026.

7/30/2026

National Institutes of Health Announces Amended Meeting Notice

The Office of the Director at the National Institutes of Health has issued an amended notice regarding a meeting, which may involve discussions and decisions by a committee or other governing body, and may be subject to certain rules or regulations, and may be open to the public or restricted to certain individuals or groups.

7/30/2026

FDA Announces Prescription Drug User Fee Rates for Fiscal Year 2027

The Food and Drug Administration is setting the rates for prescription drug user fees for the upcoming fiscal year, following the Prescription Drug User Fee Amendments of 2022, which gave the agency the authority to collect fees for certain applications and approved products.

7/30/2026

Animal Generic Drug User Fee Program Rates and Payment Procedures for Fiscal Year 2027

The Food and Drug Administration is announcing the fee rates and payment procedures for fiscal year 2027 generic new animal drug program user fees, as mandated by the Animal Generic Drug User Fee Amendments of 2023. The FDA is establishing the fee rates for FY 2027, following the amendments to the Federal Food, Drug, and Cosmetic Act.

7/30/2026

Outsourcing Facility Fee Rates for Fiscal Year 2027

The Food and Drug Administration (FDA) has announced the fiscal year 2027 rates for establishment and reinspection fees for outsourcing facilities that compound human drugs and register under the Federal Food, Drug, and Cosmetic Act. The rates include a small business establishment fee of $7,142, a non-small business establishment fee of $22,074, and a reinspection fee of $21,427.

7/30/2026

FDA Announces Generic Drug User Fee Rates for Fiscal Year 2027

The US Food and Drug Administration (FDA) has published the fiscal year 2027 rates for fees related to the review of generic drugs, as mandated by the Generic Drug User Fee Amendments of 2022 (GDUFA III). These fees will be used to support the agency's efforts to review and approve generic drug applications.

7/30/2026

FDA Announces 2027 VQIP User Fee Rate

The FDA is setting an annual fee for importers participating in the Voluntary Qualified Importer Program, which is part of the Food Safety Modernization Act, starting August 1, 2026, and ending September 30, 2027.

7/30/2026

FDA Announces Biosimilar User Fee Rates for Fiscal Year 2027

The US Food and Drug Administration (FDA) has announced the user fee rates for biosimilar biological products for fiscal year 2027, as mandated by the Biosimilar User Fee Amendments of 2022 (BsUFA III). The rates will cover various activities, including development, review, and approval of biosimilar products.